Stay updated with breaking news from Activating Construct. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Harpoon Therapeutics, Inc. (NASDAQ:HARP – Get Rating) was the recipient of a large growth in short interest in April. As of April 30th, there was short interest totalling 761,200 shares, a growth of 115.5% from the April 15th total of 353,200 shares. Based on an average daily trading volume, of 305,500 shares, the short-interest ratio […]
Harpoon Therapeutics, Inc. (NASDAQ:HARP – Get Rating) saw a significant increase in short interest in April. As of April 30th, there was short interest totalling 761,200 shares, an increase of 115.5% from the April 15th total of 353,200 shares. Currently, 3.3% of the company’s stock are sold short. Based on an average daily volume of […]
Shares of Harpoon Therapeutics, Inc. (NASDAQ:HARP – Get Rating) have been assigned a consensus rating of “Moderate Buy” from the ten research firms that are presently covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a hold rating and seven have issued a buy rating on the company. The average 12-month […]
Harpoon Therapeutics (NASDAQ:HARP – Get Rating) and Novavax (NASDAQ:NVAX – Get Rating) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, earnings, risk, valuation, profitability and analyst recommendations. Earnings and Valuation This table compares Harpoon Therapeutics and Novavax’s […]
Shares of Harpoon Therapeutics, Inc. (NASDAQ:HARP – Get Rating) were down 3.7% during trading on Monday . The company traded as low as $0.58 and last traded at $0.59. Approximately 352,029 shares were traded during trading, a decline of 15% from the average daily volume of 413,621 shares. The stock had previously closed at $0.61. […]